HCPCS J0133: Injection, Acyclovir 5 mg
HCPCS Level II code J0133 denotes an injection of acyclovir, 5 mg, used to bill for the drug component of antiviral therapy in outpatient and acute care settings. This code matters nationally because acyclovir injections are used for treatment of serious herpesvirus infections and represent a discrete billable drug unit that affects facility and professional reimbursement, supply management, and utilization tracking.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of billing implications, common billing modifiers, and the clinical context for use of injectable acyclovir. The publication outlines typical service settings where J0133 is billed and highlights policy considerations that influence coverage and prior authorization requirements.
The report provides benchmarks for unitization and billing frequency where available, summarizes payer coverage tendencies, and explains coding nuances relevant to pharmacy and infusion service lines. Data not available in the input is noted where applicable. The content is intended to inform billing staff, pharmacy managers, and policy analysts about the operational and coding aspects of HCPCS Level II code J0133.
Sign up for hcpcs J0133 policy alerts
Get alerted when payer policies referencing J0133 are released or updated.
Billing Code Overview
HCPCS Level II code J0133 represents an injection of acyclovir, 5 mg. This code describes the drug product and the unit of service for billing purposes.
Service Type: Drug administration / injectable antiviral therapy
Typical Site of Service: Outpatient infusion or injection settings, clinic, or emergency department
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient infusion center or emergency department with an acute severe herpesvirus infection (for example, disseminated herpes simplex virus or severe varicella-zoster in an immunocompromised patient) requiring intravenous antiviral therapy. The treating clinician (infectious disease specialist, emergency physician, hospitalist, or oncology/hematology team) orders IV acyclovir dosed by weight. Pharmacy compounds the supply using J0133 billed per 5 mg unit and prepares the infusion or bolus. Nursing documents medication administration, vital signs, infusion reaction monitoring, and renal function assessments before and during therapy due to acyclovir’s nephrotoxicity risk. Typical workflow steps: clinician order → pharmacy verification and dose calculation → IV preparation and labeling → bedside administration with appropriate modifier usage for billing (for example, outpatient service, emergency department service, or modifier to indicate drug wastage) → documentation of indication, dose, lot number, and patient response in the medical record.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug discarded/unused amount | When part of a single-dose vial is discarded and payer permits reporting discarded drug separately. |
JZ | No drug discarded/remaining amount | When the entire drug vial(s) prepared were administered with no leftover. |
59 | Distinct procedural service | When acyclovir injection is provided on the same date as an unrelated procedure requiring separate billing. |
25 | Significant, separately identifiable E/M on same day | When a significant evaluation and management visit is performed on the same day as the injection in an outpatient setting. |
24 | Unrelated E/M during postoperative period | When an unrelated visit occurs during a global postoperative period and IV drug is administered. |
62 | Two surgeons | If two qualified surgeons share responsibility and a procedural service related to the infection is performed concurrently (rare for drug billing; used when applicable). |
78 | Unplanned return to operating room | If administration occurs in context of an unplanned return for a related surgical procedure. |
52 | Reduced services | When the drug administration service is partially reduced or not completed as planned. |
53 | Discontinued procedure | When the administration is started but then discontinued for patient safety reasons. |
76 | Repeat procedure by same physician | (Not in provided list; omitted.) |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
208000000X | Infectious Disease | Specialists who commonly order IV acyclovir for severe viral infections. |
207R00000X | Emergency Medicine | Emergency physicians initiate IV antiviral therapy for acute presentations. |
207L00000X | Hospitalists | Manage inpatient antiviral therapy and coordinate dosing and monitoring. |
208800000X | Hematology & Medical Oncology | Manage immunocompromised patients (e.g., transplant, chemotherapy) at high risk for severe herpesvirus disease. |
363LP0800X | Infusion Therapy Nurse | Providers who administer and monitor IV antiviral infusions. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
B00.9 | Herpesviral infection, unspecified | General indication for antiviral therapy when site-specific code not documented. |
B00.3 | Disseminated herpesviral disease | Common indication for intravenous acyclovir in severe or systemic infection. |
B02.9 | Zoster without complications | Varicella-zoster presentations that may require IV therapy in severe cases or immunocompromised patients. |
B02.8 | Zoster with other complications | When complications (dissemination, ophthalmic involvement) prompt IV acyclovir. |
B00.2 | Herpesviral gingivostomatitis and pharyngotonsillitis | Severe mucocutaneous disease in adults or children sometimes treated with IV therapy in specific contexts. |
B00.7 | Disseminated herpesviral disease in the newborn | Neonatal HSV infections commonly require IV acyclovir. |
Z94.0 | Kidney transplant status | Transplant recipients are at higher risk for severe herpesvirus infections and commonly receive IV acyclovir. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
96365 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | May be billed when IV acyclovir is administered as an infusion requiring documented time and infusion setup in the outpatient setting. |
96366 | Intravenous infusion, each additional hour (list separately in addition to code for primary infusion) | Used when acyclovir infusion continues beyond the initial hour and time-based infusion reporting is permitted. |
90471 | Immunization administration (not directly related) | Data not applicable; included only when concurrent vaccine administration occurs — otherwise not typically related. |
36415 | Collection of venous blood by venipuncture | Often performed before or during IV antiviral therapy for renal function and viral testing. |
87480 | Infectious agent detection by nucleic acid (e.g., HSV PCR) | Diagnostic testing commonly performed to confirm herpes simplex or varicella-zoster infection guiding IV acyclovir use. |